Company / Profit Margin
BioNexus Gene Lab Corp Profit Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-40.2%
FY2025
5-year range
-40.2% / 5.6%
FY2021-FY2025
Trend
-139.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 7 years, ranging from -194.1% in FY2019 to 9.6% in FY2020.
Based on SEC 10-K filings.
-40.2% in FY2025 with a 5-year CAGR of -49.8%.
Declined from -26.9% to -40.2% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -36.9pp
- 5-Year Change
- -49.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 139.1% year-over-year.
- Peak profit margin was recorded in FY2020.
- Lowest profit margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -40.2% | -139.1% |
| FY2024 | -16.8% | +37.5% |
| FY2023 | -26.9% | -725.5% |
| FY2022 | -3.3% | -158.0% |
| FY2021 | 5.6% | -41.5% |
| FY2020 | 9.6% | +105.0% |
| FY2019 | -194.1% | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026